Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

NCT03269019 is registered in ClinicalTrials.gov with Wuhan Asia Heart Hospital as lead sponsor.

NCT NCT03269019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03269019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia
Lead sponsor
Wuhan Asia Heart Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 20, 2017
Completion date
December 31, 2019
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers, heparin-induced thrombocytopenia, thrombosis